Onconetix, INC. (ONCO) — 10-Q Filings

All 10-Q filings from Onconetix, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Onconetix Plunges Deeper into Red Amidst Revenue Collapse, Goodwill Hit — Nov 13, 2025 Risk: high
Onconetix, Inc. reported a significant net loss of $19,702,029 for the nine months ended September 30, 2025, a decrease from the $29,252,681 net loss in the pri
Onconetix Revenue Plummets 85% Amid Strategic Shift, Cash Dwindles — Aug 14, 2025 Risk: high
Onconetix, Inc. (ONCO) reported a significant decline in revenue and increased net loss for the six months ended June 30, 2025, compared to the same period in 2
Onconetix Files 10-Q, Maintains Emerging Growth Status — Jun 12, 2025 Risk: high
Onconetix, Inc. (ONCO) filed its 10-Q for the quarter ended March 31, 2025, indicating its status as a non-accelerated filer, a smaller reporting company, and a
Onconetix, Inc. Files Q3 2024 10-Q Report — Dec 10, 2024 Risk: low
Onconetix, Inc. filed its quarterly report for the period ending September 30, 2024. The company, formerly known as Blue Water Biotech, Inc. and Blue Water Vacc
Onconetix, Inc. Files Q2 2024 10-Q Report — Aug 29, 2024 Risk: low
Onconetix, Inc. filed its 10-Q for the quarterly period ended June 30, 2024. The company, formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines Inc
Onconetix, Inc. Files Q1 2024 10-Q Report — May 20, 2024 Risk: low
Onconetix, Inc. filed its 10-Q for the quarterly period ended March 31, 2024. The company, formerly known as Blue Water Biotech, Inc. and Blue Water Vaccines In

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX